A meta-analytic approach to estimating nocebo effects in neuropathic pain trials.
about
Placebo, nocebo, and neuropathic painNocebo as a potential confounding factor in clinical trials for Parkinson's disease treatment: a meta-analysis.Nonspecific adverse events in knee osteoarthritis clinical trials: a systematic review.The nocebo effect of drugs.The nocebo effect: a clinicians guide.Adverse events of placebo-treated, drug-resistant, focal epileptic patients in randomized controlled trials: a systematic review.Characterization of the adverse events profile of placebo-treated patients in randomized controlled trials on drug-resistant focal epilepsies.Placebo and nocebo effects in the neurological practice.Nocebo in motor neuron disease: systematic review and meta-analysis of placebo-controlled clinical trials.Types, frequencies, and burden of nonspecific adverse events of drugs: analysis of randomized placebo-controlled clinical trials.Unravelling nocebo effect: the mediating effect of anxiety between anticipation and pain at wound dressing change.Nocebo effects in clinical studies: hints for pain therapy.[Gender differences in acute and chronic pain conditions. Implications for diagnosis and therapy].Minimizing nocebo effect: Pragmatic approach.Development of the Stanford Expectations of Treatment Scale (SETS): a tool for measuring patient outcome expectancy in clinical trials.Treatment Outcomes with Biosimilars: Be Aware of the Nocebo Effect.Medicine-related beliefs predict attribution of symptoms to a sham medicine: A prospective study.What trial participants need to be told about placebo effects to give informed consent: a survey to establish existing knowledge among patients with back pain.Proton pump inhibitor-related headaches: a nationwide population-based case-crossover study in Taiwan.Nocebo effects and psychotropic drug action.Non-pharmacological Effects in Switching Medication: The Nocebo Effect in Switching from Originator to Biosimilar Agent
P2860
Q28072351-373F16DD-0EE4-4D65-99F3-7B16999C966BQ34311226-1643852A-1A90-4D1D-B7C6-5712EFED7660Q35387933-18CFD05C-1C56-401F-B1B8-67EC1DCCAA48Q36719631-D662F8EF-7398-4776-9E6A-988A7002778FQ38055026-AD9E3A95-0E9F-4728-8084-8AB80CFF1560Q38219326-091ADC7D-49D7-4CB4-A253-EC73785A8694Q38259757-7F21F5A2-27F0-4A6D-B02E-7BDA5ADA9BCBQ38327044-944C69A5-E8D8-4E2B-9B1F-01B87CD67ED3Q38736906-D8C378C6-C730-4E05-BFB8-FB965CEC1553Q38972857-1D721C1B-F517-4BF4-9190-E989B57942B9Q40880535-5DF1B0E3-8CAE-43F5-B229-DC7F661C838FQ42376620-0ADA6424-3A9C-4B19-B093-FEB1E3095156Q44391988-9378B882-DC81-40EA-BFB2-CDB5DDC67C21Q44863430-16D1F230-87E3-4661-9277-6F3AF31A828EQ45181057-56757CFB-5555-4060-8B0D-AE4BE3E11C4CQ47106974-E47A87DB-462C-4E79-9E76-EEC841F2EA6EQ48099493-932F6B5A-07B3-4684-9A40-0A9D5175C8C8Q48199107-679730BC-0070-42F0-B3AA-0DCBE8F46C06Q48289619-21FD5058-7780-4348-AD54-030B6366DF6EQ50616272-782D3800-B71B-49BD-84AC-778C1D9EDD85Q58795531-DADED9CE-BF82-43C9-B212-E9BF82A1BD48
P2860
A meta-analytic approach to estimating nocebo effects in neuropathic pain trials.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年学术文章
@wuu
2011年学术文章
@zh
2011年学术文章
@zh-cn
2011年学术文章
@zh-hans
2011年学术文章
@zh-my
2011年学术文章
@zh-sg
2011年學術文章
@yue
2011年學術文章
@zh-hant
name
A meta-analytic approach to estimating nocebo effects in neuropathic pain trials.
@en
A meta-analytic approach to estimating nocebo effects in neuropathic pain trials.
@nl
type
label
A meta-analytic approach to estimating nocebo effects in neuropathic pain trials.
@en
A meta-analytic approach to estimating nocebo effects in neuropathic pain trials.
@nl
prefLabel
A meta-analytic approach to estimating nocebo effects in neuropathic pain trials.
@en
A meta-analytic approach to estimating nocebo effects in neuropathic pain trials.
@nl
P2860
P1433
P1476
A meta-analytic approach to estimating nocebo effects in neuropathic pain trials
@en
P2093
Dimos Dimitrios Mitsikostas
P2860
P2888
P304
P356
10.1007/S00415-011-6197-4
P577
2011-08-03T00:00:00Z